27
Jul 21
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
Clinical Utility of ALK Fusion Detection by Liquid Biopsy Cell-free DNA NGS detects common and novel ALK fusions in the...
Read More
25
Jun 21
How AI Might Boost Radiology Efficiency and Effectiveness
How AI Might Boost Radiology Efficiency and Effectiveness The CentricityTM Universal Viewer1 worklist provides indications for exams with AI Findings2...
Read More
22
Jun 21
Trending AI and Digital Solutions in Radiology—current adoption, applications and continuing developments
Trending AI and Digital Solutions in Radiology—current adoption, applications and continuing developments In the wake of the global COVID-19 pandemic,...
Read More
4
Jun 21
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer MSK and Resolution Bioscience (a...
Read More
24
Mar 21
GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics
GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics GE Healthcare introduces StarGuide,...
Read More
17
Mar 21
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Announces Cash Dividend of 19.4 Cents per Share Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend...
Read More
9
Mar 21
Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection
Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection Agilent Technologies Inc. (NYSE: A) today...
Read More
9
Mar 21
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate)...
Read More
2
Mar 21
Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics Resolution Bioscience is a fast-growing, innovative leader in next-generation...
Read More
22
Feb 21
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC) Agilent Technologies Inc. (NYSE: A)...
Read More
